<?xml version="1.0" encoding="UTF-8" standalone="yes"?><?xml-stylesheet type="text/xsl" href="/oai-pmh-repository/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2026-10-15T11:46:21Z</responseDate>
    <request verb="GetRecord" identifier="oai:data.mendeley.com/vfvk3f97nh.1" metadataPrefix="oai_dc">https://data.mendeley.com/oai</request>
    <GetRecord>
        <record>
            <header>
                <identifier>oai:data.mendeley.com/vfvk3f97nh.1</identifier>
                <datestamp>2020-10-21T13:59:20Z</datestamp>
            </header>
            <metadata><oai_dc:dc xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <dc:creator>Dezoti da Fonseca, Cassiane</dc:creator>
    <dc:title>Heme Oxygenase-1 counteracts contrast-induced acute kidney injury in diabetic rats via antioxidant pathway</dc:title>
    <dc:publisher>Mendeley Data</dc:publisher>
    <dc:description>Contrast-induced acute kidney injury (CI-AKI) is the third leading cause of hospital-acquired  kidney injury. Diabetes Mellitus is an important risk factor for contrast-induced acute kidney injury and its identification is predictable. Heme oxygenase-1 (HO-1) is a new therapeutic target that exerts antioxidant effect against kidney diseases. This study investigated the effect of HO-1 on metabolic functions, oxidative profile and morphology at CI-AKI in the presence of Diabetes Mellitus. Twenty-eight male Wistar rats weighing 250-300g were randomized into four groups: C (control)- rats submitted to left uninephrectomy on the 1th day; DM- Diabetes was induced by a single dose of intravenous streptozotocin-65mg/kg on the 20th day; DMIC- iodinated contrast- meglumine ioxithalamate (6ml/kg, intraperitoneal, once) rats and DMICH- hemin (HO-1 inducer; 10mg/kg; intraperitoneal; 60 minutes before iodinated contrast) were infused on the 85th day. Diabetic groups showed polyphagia, polydipsia, polyuria, and increase in the blood glucose and in the kidney/animal weight ratio. Iodinated contrast reduced the creatinine clearance and thiols in renal tissue with a prominent increase in urinary NGAL, peroxides, oxide nitric and thiobarbituric acid-reactive substances (TBARS), these parameters were significantly changed by HO-1 inducer. Kidney histology showed tubular cells vacuolization and edema in iodinated contrast animals. The data highlight the HO-1 protective effect against contrast-induced AKI associated with chronic disease, DM.  </dc:description>
    <dc:subject>Pre-Clinical Translational Research</dc:subject>
    <dc:type>Dataset</dc:type>
    <dc:identifier>doi:10.17632/vfvk3f97nh.1</dc:identifier>
    <dc:identifier>oai:data.mendeley.com/vfvk3f97nh.1</dc:identifier>
    <dc:rights>Creative Commons Attribution 4.0 International</dc:rights>
    <dc:rights>http://creativecommons.org/licenses/by/4.0</dc:rights>
    <dc:relation>https://data.mendeley.com/datasets/vfvk3f97nh</dc:relation>
    <dc:date>2020-10-21T13:59:20Z</dc:date>
</oai_dc:dc></metadata>
        </record>
    </GetRecord>
</OAI-PMH>
